AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,757,000 | -62.7% | 36,980 | -51.7% | 0.49% | -63.7% |
Q3 2018 | $4,711,000 | +7.9% | 76,537 | +18.4% | 1.36% | -12.6% |
Q2 2018 | $4,367,000 | +95.6% | 64,655 | +57.1% | 1.55% | +8.3% |
Q1 2018 | $2,233,000 | +17.0% | 41,157 | +28.8% | 1.43% | -7.4% |
Q4 2017 | $1,909,000 | +82.5% | 31,956 | +48.5% | 1.55% | +43.8% |
Q3 2017 | $1,046,000 | – | 21,526 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 244,783 | $1,718,000 | 0.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $32,959,000 | 0.69% |
DCF Advisers, LLC | 192,065 | $1,348,000 | 0.55% |
LEVIN CAPITAL STRATEGIES, L.P. | 817,377 | $5,738,000 | 0.54% |
DAFNA Capital Management LLC | 289,040 | $2,029,000 | 0.51% |
Rhenman & Partners Asset Management AB | 750,000 | $5,378,000 | 0.36% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,175,000 | 0.31% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,203,592 | $8,449,000 | 0.30% |
AlphaCentric Advisors LLC | 137,000 | $962,000 | 0.28% |
PFM Health Sciences, LP | 1,088,566 | $7,642,000 | 0.26% |